Results 101 to 110 of about 3,943 (193)
A review of gene therapy in canine and feline models of lysosomal storage disorders [PDF]
Bradbury, Allison M +5 more
core +2 more sources
Gangliosidosis (ORPHA: 79255) is an autosomal recessive lysosomal storage disease (LSD) with a variable phenotype and an incidence of 1:200000 live births.
Dana Elena Mîndru +9 more
doaj +1 more source
Gene Therapy Approaches for Neurological Lysosomal Storage Diseases [PDF]
GM1 and GM2 gangliosidosis are lysosomal storage diseases caused by deficiency of enzymes required for ganglioside catabolism. Enzyme deficiencies cause neuronal accumulation of ganglioside resulting in progressive neurodegeneration and premature death ...
McCurdy, Victoria
core
GM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000.
R.C. Balestrin +6 more
doaj
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations [PDF]
Helena Poupětová +5 more
core +1 more source
GM1 and GM2-Gangliosidosis: Clinical Features, Neuroimaging Findings and electroencephalography [PDF]
ObjectivesGangliosidosis is one of the hereditary metabolic diseases caused by the accumulation of Gangliosid in the central nervous system, leading to severe and progressive neurological deficits.
Ahmad Abadi, Farzad +4 more
core +1 more source
Proceedings 35th Symposium ESVN‐ECVN
Journal of Veterinary Internal Medicine, Volume 39, Issue 2, March/April 2025.
wiley +1 more source
Anesthesia outcomes in lysosomal disorders: CLN3 and GM1 gangliosidosis. [PDF]
Luckett A +8 more
europepmc +1 more source
GM1‐gangliosidosis type I [PDF]
Jiri, Pavlu +2 more
openaire +2 more sources

